Compounds > zidovudine
Page last updated: 2024-08-23

zidovudine and Sexually Transmitted Disease, Viral

zidovudine has been researched along with Sexually Transmitted Disease, Viral in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (66.67)18.2507
2000's3 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benech, H; Bourry, O; Brochard, P; Calvo, J; Dereudre-Bosquet, N; Kazanji, M; Le Grand, R; Makuwa, M; Martinon, F; Souquiere, S1
Chen, Z; Phillips, DM; Wu, Z1
Newell, ML; Scaravelli, G; Thorne, C1
Arici, C; Costigliola, P; Gasparini, M; Lazzarin, A; Musicco, M; Nicolosi, A; Saracco, A1
Lee, CA1
Barnes, L; Darby, C; Fogarty, J; Mulcahy, F; Murphy, GM; O'Connor, WJ; O'Moore, R1
Angel, JB; Cameron, DW; Garber, GE; Hawley-Foss, N; Houston, S; Kravcik, S; Sutherland, D; Victor, G1
Bersoff-Matcha, S; Horgan, M1
Bamberger, JD; Chambers, D; Chesney, M; Coates, TJ; Franses, K; Kahn, JO; Katz, MH; Martin, JN; Roland, ME1

Reviews

1 review(s) available for zidovudine and Sexually Transmitted Disease, Viral

ArticleYear
Transfusion-transmitted disease.
    Bailliere's clinical haematology, 1996, Volume: 9, Issue:2

    Topics: Blood; Blood Coagulation Factors; Carcinoma, Hepatocellular; Comorbidity; Creutzfeldt-Jakob Syndrome; Drug Contamination; Erythema Infectiosum; Hemophilia A; Hepatitis, Viral, Human; HIV Infections; Humans; Life Expectancy; Liver Neoplasms; Liver Transplantation; Lymphoma, AIDS-Related; Parvovirus B19, Human; Prognosis; Sexually Transmitted Diseases, Viral; Survival Analysis; Thrombocytopenia; Transfusion Reaction; Virus Diseases; Zidovudine

1996

Other Studies

8 other study(ies) available for zidovudine and Sexually Transmitted Disease, Viral

ArticleYear
Prevention of vaginal simian immunodeficiency virus transmission in macaques by postexposure prophylaxis with zidovudine, lamivudine and indinavir.
    AIDS (London, England), 2009, Feb-20, Volume: 23, Issue:4

    Topics: Administration, Oral; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Indinavir; Injections, Subcutaneous; Lamivudine; Macaca fascicularis; Sexually Transmitted Diseases, Viral; Simian Acquired Immunodeficiency Syndrome; Vagina; Viral Load; Viremia; Zidovudine

2009
Human genital epithelial cells capture cell-free human immunodeficiency virus type 1 and transmit the virus to CD4+ Cells: implications for mechanisms of sexual transmission.
    The Journal of infectious diseases, 2003, Nov-15, Volume: 188, Issue:10

    Topics: CD4-Positive T-Lymphocytes; Cervix Uteri; Coculture Techniques; DNA, Viral; Epithelial Cells; Female; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Polymerase Chain Reaction; Sexually Transmitted Diseases, Viral; Viral Matrix Proteins; Virus Replication; Zidovudine

2003
The management of pregnancy and delivery in HIV-infected women in Europe.
    European journal of obstetrics, gynecology, and reproductive biology, 1995, Volume: 62, Issue:1

    Topics: Blood Transfusion; Delivery, Obstetric; Europe; Female; HIV Infections; Hospitals; Humans; Infectious Disease Transmission, Vertical; Mass Screening; Pregnancy; Pregnancy Complications, Infectious; Sexually Transmitted Diseases, Viral; Substance Abuse, Intravenous; Zidovudine

1995
Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Italian Study Group on HIV Heterosexual Transmission.
    Archives of internal medicine, 1994, Sep-12, Volume: 154, Issue:17

    Topics: Acquired Immunodeficiency Syndrome; Cohort Studies; Confounding Factors, Epidemiologic; Female; HIV Seronegativity; HIV-1; Humans; Incidence; Male; Sexual Behavior; Sexual Partners; Sexually Transmitted Diseases, Viral; Zidovudine

1994
Porphyrin abnormalities in acquired immunodeficiency syndrome.
    Archives of dermatology, 1996, Volume: 132, Issue:12

    Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Anti-HIV Agents; Case-Control Studies; Feces; Female; Hepatitis C; Hepatitis C Antibodies; HIV Infections; HIV Seropositivity; Humans; Immunocompromised Host; Male; Photosensitivity Disorders; Porphyria Cutanea Tarda; Porphyrins; Prospective Studies; Sexually Transmitted Diseases, Viral; Substance Abuse, Intravenous; Zidovudine

1996
Effect of antiretroviral therapy and viral load on the perceived risk of HIV transmission and the need for safer sexual practices.
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1998, Oct-01, Volume: 19, Issue:2

    Topics: Anti-HIV Agents; Attitude to Health; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Lamivudine; Male; Protease Inhibitors; Reverse Transcriptase Inhibitors; Risk Factors; Sexual Behavior; Sexual Partners; Sexually Transmitted Diseases, Viral; Surveys and Questionnaires; Viral Load; Zidovudine

1998
Sexually transmitted diseases and HIV. A female perspective.
    Dermatologic clinics, 1998, Volume: 16, Issue:4

    Topics: Anti-HIV Agents; Epidemiologic Factors; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Infertility, Female; Male; Pelvic Pain; Pregnancy; Pregnancy Complications, Infectious; Pregnancy, Ectopic; Sexually Transmitted Diseases, Viral; Uterine Cervical Neoplasms; Women's Health; Zidovudine

1998
Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study.
    The Journal of infectious diseases, 2001, Mar-01, Volume: 183, Issue:5

    Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Contact Tracing; Counseling; Didanosine; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Nelfinavir; Patient Compliance; Reverse Transcriptase Inhibitors; Risk Factors; Risk-Taking; Sexually Transmitted Diseases, Viral; Substance Abuse, Intravenous; Time Factors; Zidovudine

2001